4. The MENQOL-Intervention survey consists of 32 questions/symptoms divided into 5 domains: vasomotor (3 questions), psychosocial (7 questions), physical (16 questions), sexual (3 questions) and medical intervention (3 questions). Prior to the trial commencing, MPowder trialists are asked whether they have experienced a particular symptom in the previous week and how bothered they are by the symptom from “0” (not at all bothered) to “6” (extremely bothered), in a Likert scale format. In addition, they are asked to track key symptoms on a weekly basis to allow us to evaluate the typical time frame in which participants saw results against those symptoms. Higher MENQOL scores indicate poorer quality of life.
5. No: 30 women, 8 week trial duration, May-July 2020.
6. No: 25 women, 8 week trial duration, Feb-April 2021